Cargando…
Synergistic Anticancer Effects of Vorinostat and Epigallocatechin-3-Gallate against HuCC-T1 Human Cholangiocarcinoma Cells
The aim of this study was to investigate the effect of the combination of vorinostat and epigallocatechin-3-gallate against HuCC-T1 human cholangiocarcinoma cells. A novel chemotherapy strategy is required as cholangiocarcinomas rarely respond to conventional chemotherapeutic agents. Both vorinostat...
Autores principales: | Kwak, Tae Won, Kim, Do Hyung, Chung, Chung-Wook, Lee, Hye Myeong, Kim, Cy Hyun, Jeong, Young-IL, Kang, Dae Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706064/ https://www.ncbi.nlm.nih.gov/pubmed/23864881 http://dx.doi.org/10.1155/2013/185158 |
Ejemplares similares
-
Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2016) -
Synergistic effect of curcumin on epigallocatechin gallate-induced anticancer action in PC3 prostate cancer cells
por: Eom, Dae-Woon, et al.
Publicado: (2015) -
Antitumor activity of vorinostat-incorporated nanoparticles against human cholangiocarcinoma cells
por: Kwak, Tae Won, et al.
Publicado: (2015) -
Synergistic effects of 5-aminolevulinic acid based photodynamic therapy and celecoxib via oxidative stress in human cholangiocarcinoma cells
por: Kim, Cy Hyun, et al.
Publicado: (2013) -
Anticancer effects and molecular mechanisms of epigallocatechin-3-gallate
por: Min, Kyoung-jin, et al.
Publicado: (2014)